TickerFacts.

DaVita Inc. (DVA): Cash & Equivalents

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2015-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$676.44M
As of 2025-12-31
$668.96M
As of 2026-06-30
+40.5%
3-year compound annual growth
+15.8%
5-year compound annual growth
-5.9%
10-year compound annual growth
$1.24B2007-12-31: $447.05M2008-12-31: $410.88M2009-12-31: $539.46M2010-12-31: $860.12M2011-12-31: $393.75M2012-12-31: $533.75M2013-12-31: $946.25M2014-12-31: $965.24M2015-12-31: $1.24B2016-12-31: $674.78M2017-12-31: $508.23M2018-12-31: $323.04M2019-12-31: $1.10B2020-12-31: $324.96M2021-12-31: $461.90M2022-12-31: $244.09M2023-12-31: $380.06M2024-12-31: $794.93M2025-12-31: $676.44M$676.44M
2007-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$676.44M-14.9%2026-02-11, Balance as of period end
2024-12-31$794.93M+109.2%2026-02-11, Balance as of period end
2023-12-31$380.06M+55.7%2025-02-13, Balance as of period end
2022-12-31$244.09M-47.2%2024-02-14, Balance as of period end
2021-12-31$461.90M+42.1%2023-02-22, Balance as of period end
2020-12-31$324.96M-70.5%2022-02-11, Balance as of period end
2019-12-31$1.10B+241.3%2021-02-12, Balance as of period end
2018-12-31$323.04M-36.4%2020-02-21, Balance as of period end
2017-12-31$508.23M-24.7%2019-02-22, Balance as of period end
2016-12-31$674.78M-45.8%2018-02-23, Balance as of period end
2015-12-31$1.24Bn/c2018-02-23, Balance as of period end
2014-12-31$965.24M+2.0%2017-02-24, Balance as of period end
2013-12-31$946.25M+77.3%2016-02-26, Balance as of period end
2012-12-31$533.75M+35.6%2015-02-26, Balance as of period end
2011-12-31$393.75M-54.2%2014-02-21, Balance as of period end
2010-12-31$860.12M+59.4%2013-03-01, Balance as of period end
2009-12-31$539.46M+31.3%2012-02-24, Balance as of period end
2008-12-31$410.88M-8.1%2011-02-25, Balance as of period end
2007-12-31$447.05Mn/a2010-02-25, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Services-Misc Health & Allied Services, NEC), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
DaVita Inc. (DVA)2025-12-31$676.44M-14.9%
agilon health, inc. (AGL)2025-12-31$173.71M-7.7%
Progyny, Inc. (PGNY)2025-12-31$112.24M-30.9%
Sotera Health Co (SHC)2025-12-31$344.62M+24.3%
Viemed Healthcare, Inc. (VMD)2025-12-31$13.50M-23.0%
Cryo Cell International Inc (CCEL)2025-11-30$319.0K-43.1%
Marpai, Inc. (MRAI)2025-12-31$133.0K-82.6%
Pacific Health Care Organization Inc (PFHO)2025-12-31$2.17M+4.7%
Charming Medical Ltd (MCTA)2026-03-31$4.70M+475.3%

Compare DVA, AGL, PGNY, SHC side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗